Compare Bristol-Myers Squibb Co (BMY) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs AT&T Inc. — how do they compare? Bristol-Myers Squibb Co trades at $63.57 (market cap $129.94B), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: AT&T Inc. is the larger of the two by market cap, and AT&T Inc. pays the higher dividend (4.53%). Which is the better fit depends on your goals.
| BMY | T | |
|---|---|---|
Market Cap | $129.94B | $167.88B |
Sector | Health | Media |
52-Week High | $65.89 | $29.62 |
52-Week Low | $42.60 | $20.49 |
Enterprise Value | $163.92B | $313.20B |
Dividend Yield | 3.96% | 4.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
